Health
Phase 3 trial: New biologic therapy improves outcomes in adults, adolescents with severe asthma – News-Medical.Net
Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency…
Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, uncontrolled asthma, according to research presented at the ATS 2021 International Conference. NAVIGATOR (NCT03347279) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial.
Tezepelumab offers new therapeutic opportunities for patients…
-
Noosa News14 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News24 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
General21 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
General20 hours agoJordan Thompson retires from Wimbledon round-of-16 match with American Taylor Fritz